Septerna CEO to present at Bank of America Health Care Conference on May 12, 2026

Septerna, a clinical-stage biotech company specializing in GPCR drug discovery, announced that CEO Jeffrey Finer will present at the Bank of America Securities Health Care Conference on May 12, 2026, in Las Vegas. The presentation will be webcast live and archived on Septerna's website. The company is advancing novel oral small molecule drug candidates for diseases in endocrinology, immunology, inflammation, and metabolic disorders. This event highlights Septerna's ongoing progress and commitment to innovative therapies for unmet medical needs.